CompanyDrug

Grand Pharma’s TLX101 Accepted for NMPA Review for Glioblastoma Treatment

CompanyDeals

Forlong Biotechnology Secures Series A Funding for Protein Drug Development

CompanyDeals

Zhimeng Biopharma Signs Global Licensing Deal with GSK for TLR8 Agonist CB06

CompanyDeals

Haisco Pharmaceutical Announces Public Offering for Clinical Studies

CompanyDrug

BDgene’s CRISPR-Cas9 Therapy BD111 Accepted for CDE Review

CompanyDrug

JunTop Biosciences’ COVID-19 Therapy Mindewei Priced at RMB 795 per Course

CompanyDeals

Ji Xing Pharmaceuticals Acquires Global Rights to PhaseBio’s PB6440

CompanyDrug

Mabwell’s Novel ADC 9MW2921 Accepted for NMPA Review

Company

Amgen Reports Q4 and Full-Year 2022 Financials with Global Sales Growth

Company

GSK Reports Strong Q4 and Full-Year 2022 Financials Amid Strategic Shift

Policy / Regulatory

China’s NMPA Releases 64th Batch of Reference Drugs for Generic Quality Consistency Evaluation

CompanyDrug

Bristol-Myers Squibb’s Ozanimod Approved in China for Multiple Sclerosis